Watch MMSI. Know when insiders buy.
One email the day a filing lands. Free.
Work order
50
WATCH · insiders 28, shorts 71
Insiders, 90 days
−$678K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $5.4BP/E 36.9DIV YIELD —FCF YIELD 3.80%REV TTM $1.6B +10.2%NET INCOME $145.6M +22.2%NET DEBT $287.6M52W 60.31 – 93.18SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $418.8M | +9.5% | 51.4% | $60.4M | $38.8M | +19.1% | 0.65 | $69.3M | $17.3M | $51.9M | Jul 30 |
| Q1 2026 · Mar 31 | $381.9M | +7.5% | 48.4% | $44.2M | $41M | +36.0% | 0.68 | $40.7M | $16M | $24.7M | Jul 30 |
| Q4 2025 · Dec 31derived | $393.9M | +10.9% | 49.6% | $54.2M | $38M | +36.0% | 0.64 | $98.5M | $24.5M | $74M | Feb 24 |
| Q3 2025 · Sep 30 | $384.2M | +13.0% | 48.5% | $42.6M | $27.8M | −2.4% | 0.46 | $75M | $22.4M | $52.5M | Oct 30 |
| Q2 2025 · Jun 30 | $382.5M | +13.2% | 48.2% | $46.9M | $32.6M | −8.8% | 0.54 | $83.3M | $13.8M | $69.6M | Jul 30 |
| Q1 2025 · Mar 31 | $355.4M | +9.8% | 48.4% | $41M | $30.1M | +6.8% | 0.49 | $40.6M | $21.1M | $19.5M | Jul 30 |
| Q4 2024 · Dec 31derived | $355.2M | +9.4% | 48.7% | $36.6M | $27.9M | +1.2% | 0.46 | $68.7M | $3.5M | $65.3M | Feb 24 |
| Q3 2024 · Sep 30 | $339.8M | +7.8% | 46.4% | $37.3M | $28.4M | +10.1% | 0.48 | $47.3M | $9.4M | $38M | Oct 30 |
| Q2 2024 · Jun 30 | $338M | — | 47.7% | $45.9M | $35.7M | — | 0.61 | $68.5M | $10.6M | $57.9M | Oct 30 |
| Q1 2024 · Mar 31 | $323.5M | — | 46.9% | $35.9M | $28.2M | — | 0.48 | $36.2M | $11.7M | $24.5M | Oct 30 |
| Q4 2023 · Dec 31derived | $324.5M | — | 46.4% | $33.6M | $27.6M | — | 0.48 | $62.3M | $7.1M | $55.1M | Feb 24 |
| Q3 2023 · Sep 30 | $315.2M | — | 45.1% | $35.1M | $25.8M | — | 0.44 | $51.1M | $8.6M | $42.5M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.5B | 48.7% | $184.7M | $128.5M | 8.5% | 2.13 | $297.4M | $81.7M | $215.7M | — | — |
| FY2024 · to Dec 31 | $1.4B | 47.4% | $155.7M | $120.4M | 8.9% | 2.03 | $220.8M | $35.1M | $185.7M | — | — |
| FY2023 · to Dec 31 | $1.3B | 46.4% | $123.9M | $94.4M | 7.5% | 1.62 | $145.2M | $34.3M | $110.9M | — | — |
| FY2022 · to Dec 31 | $1.2B | 45.1% | $87.6M | $74.5M | 6.5% | 1.29 | $114.3M | $45M | $69.3M | — | — |
| FY2021 · to Dec 31 | $1.1B | 45.2% | $60.9M | $48.5M | 4.5% | 0.84 | $147.2M | $27.9M | $119.3M | — | — |
| FY2020 · to Dec 31 | $963.9M | 41.6% | −$1.6M | −$9.8M | -1.0% | -0.18 | $165.3M | $46M | $119.3M | — | — |
Every number comes from MERIT MEDICAL SYSTEMS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.